Tianjin Tianyao Pharmaceuticals (600488.SH) plans to pay a dividend of 0.087 yuan per share in 2023, with a record date of June 14th.

Tianjin Tianyao Pharmaceuticals (600488.SH) announced that it plans to distribute a cash dividend of 0.087 yuan per share for the 2023 fiscal year.

Zhitong FinanceJun 5 17:29

Tianjin Pharmaceutical (600488.SH): As of May 20, 2024, the number of shareholders of the company was 4,3565

Gelonghui, May 21丨Jinyao Pharmaceutical (600488.SH) said on the investor interactive platform that as of May 20, 2024, the number of shareholders of the company was 43,565.

Gelonghui FinanceMay 21 16:01

Tianjin Pharmaceutical (600488.SH): Sales of API products have covered more than 70 countries and regions around the world, including South America, Asia and Europe

Gelonghui May 15 丨 Jinyao Pharmaceutical (600488.SH) said at the performance briefing that the company has always attached importance to the international market. Up to now, the company's sales of API products have covered more than 70 countries and regions around the world, including South America, Asia and Europe. Some varieties of process technology and product quality have reached the international advanced level, and it is a scientific research, production and export base for steroidal hormone drugs in Asia. In terms of pharmaceutical products, the company has successively commercialized methylprednisolone tablets, prednisone tablets, and injectable methylprednisolone sodium succinate in the US market. Among them, methylprednisolone tablets have maintained a leading share in the US market for 3 consecutive years; it is emerging

Gelonghui FinanceMay 15 20:05

Zhitong A Share Sale Restriction and Release List | May 15

According to the Zhitong Finance App, the ban on restricted shares of 3 listed companies was lifted on May 15, with a total market value of about 16.3531 million yuan. Today's specific sales restrictions and unbanned stocks are as follows: Stock abbreviation, stock code, restricted stock type, number of shares unbanned, Jinyao Pharmaceutical 600,488, share incentives, 2,046 million, Quanzhi Technology 300,458 share incentives, 247,000, Puyuan Jingdian, 68,337.39 million

Zhitong FinanceMay 15 09:00

Tianjin Pharmaceutical (600488.SH): Some product development and production processes involve synthetic biology-related technologies

Gelonghui, May 13丨Jinyao Pharmaceutical (600488.SH) said on the investor interactive platform that the development and production process of some of the company's products involves synthetic biology-related technology.

Gelonghui FinanceMay 13 17:29

Jinyao Pharmaceutical Gets Nod to Market Betamethasone Dipropionate in Europe

Jinyao Pharmaceutical (SHA:600488) is now allowed to sell its raw drug ingredient, betamethasone dipropionate, in Europe after obtaining the Certification of Suitability from the European Directorate

MT NewswiresMay 9 13:10